HR8 (2021) Detail

Requesting an investigation on whether opioids, benzodiazepines, and exposure to chemical agents contribute to suicides by veterans.


HR 8 - AS AMENDED BY THE HOUSE

 

24Feb2021... 0097h

2021 SESSION

21-0182

06/05

 

HOUSE RESOLUTION 8

 

A RESOLUTION requesting an investigation on whether opioids, benzodiazepines, and exposure to chemical agents contribute to suicides by veterans.

 

SPONSORS: Rep. Abramson, Rock. 37; Rep. Greeson, Graf. 16; Rep. Ankarberg, Straf. 10

 

COMMITTEE: State-Federal Relations and Veterans Affairs

 

-----------------------------------------------------------------

 

AMENDED ANALYSIS

 

This resolution requests that the United States Congress, the Department of Defense, and the Veterans Administration continue to investigate whether opioids, benzodiazepines, and exposure to agent orange contribute to a higher rate of suicides by veteran members of the armed forces and whether veterans who seek treatment for conditions that cause pain should receive alternative treatments before receiving prescriptions for opioids.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

 

24Feb2021... 0097h 21-0182

06/05

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty One

 

A RESOLUTION requesting an investigation on whether opioids, benzodiazepines, and exposure to chemical agents contribute to suicides by veterans.

 

Whereas, in fiscal 2012, the Veterans Administration issued benzodiazepines to 28 percent of the 640,000 veterans seen for post traumatic stress disorder (PTSD), and the amount of prescriptions at the Veterans Administration for these drugs amounted to 2.4 million in fiscal 2014; and

Whereas, 27 percent of veterans who received opioid analgesics from 2004-2009 also received benzodiazepines; and

Whereas, benzodiazepines can be addictive and can possibly enhance fear following trauma and suicidal thoughts, they also have some valid uses, such as stopping panic attacks from escalating, easing sleep disorders, and helping agitated patients at high risk of harm to themselves or others; and

Whereas, the 2015 suicide rate for female veterans receiving care through the Veterans Health Administration was 17.8 per 100,000, compared to 45.6 male veterans under care; and

Whereas, the Department of Veterans Affairs now reports that the New Hampshire veterans suicide rate of 33 per year was, "significantly higher than the national suicide rate;" and

Whereas, 20.6 armed service veterans are taking their own lives each day, substantially higher than the national average, with the suicide rate for veterans aged 18-34 increased substantially to 45 deaths per 100,000; and

Whereas, while the Veterans Administration's clinical practice guidelines recommend against their use in patients with PTSD due to "lack of efficacy data and growing evidence for the potential risk of harm," physicians often prescribe them to patients who come to them already taking those medications because abruptly stopping them can incur serious risks; and

Whereas, the suicide rate among veterans ages 18 to 27 receiving care at VA medical facilities is 79 per 100,000, and suicide rates among armed service veterans receiving care has been substantially higher than among those not under care; now, therefore, be it

Resolved by the House of Representatives:

That the New Hampshire house of representatives respectfully urges the Congress of the United States, the Department of Defense, and the Department of Veterans Affairs to continue to investigate whether opioids, benzodiazepines, exposure to agent orange,  insecticides,  pyridostigmine bromide, and nerve agents including, but not limited to, sarin and cyclosarin, as well as vaccines administered to military personnel such as Mefloquine, and constant, long term stress from service in the theater of operations are contributing to the high number of suicides by veteran members of the armed forces and whether veteran members of the armed forces who seek treatment for conditions that cause pain should receive alternative treatments such as chiropractic, physical therapy, occupational therapy, acupuncture, massage therapy, and/or osteopathic manipulation before receiving prescriptions for opioids; and

That the house clerk forward official copies of this resolution to the President of the United States, the Speaker of the United States House of Representatives, the President of the United States Senate, the Secretary of Defense, the Secretary of Veterans Affairs, and to all the members of the New Hampshire congressional delegation with the request that this resolution be officially entered in the Congressional Record as a high priority for the Congress of the United States of America.

Links

HR8 at GenCourtMobile
HR8 Discussion

Action Dates

Date Body Type
Jan. 29, 2021 House Hearing
Feb. 5, 2021 House Exec Session
Feb. 12, 2021 House Exec Session
House Floor Vote

Bill Text Revisions

HR8 Revision: 32152 Date: Feb. 26, 2021, 12:24 p.m.
HR8 Revision: 31537 Date: Jan. 9, 2021, 1:43 p.m.

Docket


Feb. 24, 2021: Ought to Pass with Amendment 2021-0097h: MA VV 02/24/2021


Feb. 24, 2021: Amendment # 2021-0097h: AA VV 02/24/2021


: Committee Report: Ought to Pass with Amendment # 2021-0097h (Vote 21-0; CC) HC 12 P. 13


Feb. 12, 2021: Executive Session: 02/12/2021 09:00 am Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/93009507127


Feb. 5, 2021: Executive Session: 02/05/2021 10:00 am Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/93691497982 (if not voted on Jan. 29th)


Jan. 29, 2021: Public Hearing: 01/29/2021 02:30 pm Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/95866113093 / Executive session on pending legislation may be held throughout the day (time permitting) from the time the committee is initially convened.


Jan. 6, 2021: Introduced (in recess of) 01/06/2021 and referred to State-Federal Relations and Veterans Affairs HJ 2 P. 50